One important metric to look for in a stock is an 80 or higher Relative Strength Rating. Constellium Cl A cleared that benchmark Friday, with a jump from 79 to 82 Friday.
Hone Your Stock-Picking Skills By Focusing On These Factors
IBD's unique RS Rating tracks market leadership by using a 1 (worst) to 99 (best) score that identifies how a stock's price performance over the last 52 weeks matches up against the rest of the market.
Decades of market research shows that the best stocks typically have an RS Rating north of 80 in the early stages of their moves.
Constellium Cl A is trading within a buy range after climbing above a 15.43 entry in a consolidation. Once a stock moves 5% or higher beyond the initial entry, it's considered out of buy range.
Earnings growth fell in the most recent report from 86% to -51%. But sales moved higher, from 5% to 9%. Look for the next report on or around Oct. 22.
Constellium Cl A earns the No. 3 rank among its peers in the Steel-Specialty Alloys industry group. ATI is the top-ranked stock within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
IBD Stock Rating Upgrades: Rising Relative Strength
